An Analysis of Presentation and Outcome Following Treatment of Pancreatic Endocrine Neoplasms
A Single Centre Analysis of Clinical Characteristics and Treatment of Endocrine Pancreatic Tumours.
1 other identifier
observational
40
0 countries
N/A
Brief Summary
A single institutional study of Pancreatic Endocrine Neoplasms over 18 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2011
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
March 23, 2015
CompletedFirst Posted
Study publicly available on registry
March 27, 2015
CompletedResults Posted
Study results publicly available
April 29, 2015
CompletedApril 29, 2015
April 1, 2015
3 months
March 23, 2015
March 26, 2015
April 10, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Nonfunctioning and Malignant Pancreatic Endocrine Neoplasms
Of the 40 patients operated for Pancreatic Endocrine Neoplasms, using clinical criteria, histopathological analysis and preoperative imaging as gold standard, nonfunctioning and functioning tumours were identified. Similarly the number of benign and malignant lesions identified were recorded as per the WHO Classification of pancreatic endocrine tumours.
Each participant was followed up for a period of 5 years
Study Arms (1)
Pancreatic Endocrine Neoplasms
We did an observational analysis from a prospectively maintained database of patients who underwent pancreatic surgery for neoplasms of the pancreas at Sir Ganga Ram Hospital, New Delhi, India from 1995 to 2013 and using pathological reports and preoperative CT scan as gold standard, we identified 40 patients with PENs.
Eligibility Criteria
Medical files and electronic records were reviewed to collect information. Patients were categorized into functioning and nonfunctioning PENs based on their clinical behaviour, pathology reports and serum radioimmunoassay for offending hormones. Preoperative CT scans were used to characterize PENs and record neoplasm size and location in the pancreas. Review of operative notes was done for the type of surgery performed and peroperative findings recorded. Discharge summaries were used to study the surgical outcome in terms of duration of postoperative hospital stay and postoperative complications. Patients were followed up and any disease recurrence or disease related mortality was recorded. Evaluation of the pathology reports was done.
You may qualify if:
- Pathological reports and Prooperative CAT Scan showing Endocrine Pancreatic Tumours
You may not qualify if:
- Nonendocrine Pancreatic Tumours
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medical College and Hospital Kolkatalead
- Sir Ganga Ram Hospitalcollaborator
Related Publications (5)
Vortmeyer AO, Huang S, Lubensky I, Zhuang Z. Non-islet origin of pancreatic islet cell tumors. J Clin Endocrinol Metab. 2004 Apr;89(4):1934-8. doi: 10.1210/jc.2003-031575.
PMID: 15070966BACKGROUNDHalfdanarson TR, Rabe KG, Rubin J, Petersen GM. Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol. 2008 Oct;19(10):1727-33. doi: 10.1093/annonc/mdn351. Epub 2008 May 30.
PMID: 18515795BACKGROUNDKazanjian KK, Reber HA, Hines OJ. Resection of pancreatic neuroendocrine tumors: results of 70 cases. Arch Surg. 2006 Aug;141(8):765-9; discussion 769-70. doi: 10.1001/archsurg.141.8.765.
PMID: 16924083RESULTVagefi PA, Razo O, Deshpande V, McGrath DJ, Lauwers GY, Thayer SP, Warshaw AL, Fernandez-Del Castillo C. Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005. Arch Surg. 2007 Apr;142(4):347-54. doi: 10.1001/archsurg.142.4.347.
PMID: 17438169RESULTHeitz PU, Komminoth P, Perrin A et al. Pancreatic endocrine tumors: Introduction. In: DeLellis DA, Lloyd RV, Heitz PU, et al., eds. Pathology and Genetics of Tumours of Endocrine Organs. WHO Classification of Tumours. Lyon, France: IARC Press, 2004: 177-82.
RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
The analysis was done from a prospectively maintained database and target followup done for a period of 5 years after surgery
Results Point of Contact
- Title
- Md Tanveer Adil
- Organization
- Sir Ganga Ram Hospital, New Delhi, India
Study Officials
- PRINCIPAL INVESTIGATOR
Md Tanveer Adil
Sir Ganga Ram Hospital, New Delhi
- STUDY DIRECTOR
Raghavendra Nagaraja
Sir Ganga Ram Hospital, New Delhi
- STUDY DIRECTOR
Vibha Varma
Sir Ganga Ram Hospital, New Delhi
- STUDY DIRECTOR
Naimish Mehta
Sir Ganga Ram Hospital, New Delhi
- STUDY DIRECTOR
Vinay Kumaran
Sir Ganga Ram Hospital, New Delhi
- STUDY CHAIR
Samiran Nundy
Sir Ganga Ram Hospital, New Delhi
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Fellow
Study Record Dates
First Submitted
March 23, 2015
First Posted
March 27, 2015
Study Start
March 1, 2011
Primary Completion
June 1, 2011
Study Completion
November 1, 2014
Last Updated
April 29, 2015
Results First Posted
April 29, 2015
Record last verified: 2015-04